WO2008029942A1 - Utilisation du gène de l'enzyme de biosynthèse de la cytokinine activée - Google Patents
Utilisation du gène de l'enzyme de biosynthèse de la cytokinine activée Download PDFInfo
- Publication number
- WO2008029942A1 WO2008029942A1 PCT/JP2007/067558 JP2007067558W WO2008029942A1 WO 2008029942 A1 WO2008029942 A1 WO 2008029942A1 JP 2007067558 W JP2007067558 W JP 2007067558W WO 2008029942 A1 WO2008029942 A1 WO 2008029942A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cytokinin
- gene
- protein
- seq
- nucleotide
- Prior art date
Links
- 108090000790 Enzymes Proteins 0.000 title abstract description 27
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 235
- 239000004062 cytokinin Substances 0.000 claims abstract description 131
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 claims abstract description 131
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 101
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 41
- 239000002773 nucleotide Substances 0.000 claims abstract description 19
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 19
- 230000000295 complement effect Effects 0.000 claims abstract description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 14
- 241000196324 Embryophyta Species 0.000 claims description 107
- 239000013598 vector Substances 0.000 claims description 50
- 150000001413 amino acids Chemical class 0.000 claims description 49
- 230000000694 effects Effects 0.000 claims description 46
- 210000004027 cell Anatomy 0.000 claims description 33
- 230000015572 biosynthetic process Effects 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 32
- 239000000758 substrate Substances 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 14
- 230000014509 gene expression Effects 0.000 claims description 10
- 210000004748 cultured cell Anatomy 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 210000000056 organ Anatomy 0.000 claims description 7
- 210000003462 vein Anatomy 0.000 claims description 5
- 238000009396 hybridization Methods 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 17
- 238000007792 addition Methods 0.000 abstract description 4
- 238000012217 deletion Methods 0.000 abstract description 3
- 230000037430 deletion Effects 0.000 abstract description 3
- 238000006467 substitution reaction Methods 0.000 abstract description 3
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 76
- 238000006243 chemical reaction Methods 0.000 description 38
- 108020004414 DNA Proteins 0.000 description 29
- 101150079178 log gene Proteins 0.000 description 27
- 235000001014 amino acid Nutrition 0.000 description 18
- 239000002609 medium Substances 0.000 description 17
- 241000588724 Escherichia coli Species 0.000 description 15
- DUISZFLWBAPRBR-OXUWNYNTSA-N isopentenyladenosine monophosphate Natural products P(=O)(OC[C@H]1[C@H](O)[C@H](O)[C@@H](n2c3ncnc(NC/C=C(\C)/C)c3nc2)O1)(O)O DUISZFLWBAPRBR-OXUWNYNTSA-N 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- 240000007594 Oryza sativa Species 0.000 description 13
- 235000007164 Oryza sativa Nutrition 0.000 description 13
- 235000009566 rice Nutrition 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 241000589158 Agrobacterium Species 0.000 description 10
- 239000007795 chemical reaction product Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 108010048581 Lysine decarboxylase Proteins 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 230000035784 germination Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 8
- 241000219195 Arabidopsis thaliana Species 0.000 description 8
- 206010020649 Hyperkeratosis Diseases 0.000 description 8
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 108010050516 adenylate isopentenyltransferase Proteins 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- GOSWTRUMMSCNCW-HNNGNKQASA-N 9-ribosyl-trans-zeatin Chemical compound C1=NC=2C(NC\C=C(CO)/C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O GOSWTRUMMSCNCW-HNNGNKQASA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HYVABZIGRDEKCD-UHFFFAOYSA-N N(6)-dimethylallyladenine Chemical compound CC(C)=CCNC1=NC=NC2=C1N=CN2 HYVABZIGRDEKCD-UHFFFAOYSA-N 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 6
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 230000009257 reactivity Effects 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 6
- 241000219194 Arabidopsis Species 0.000 description 5
- 108010076744 Arabidopsis cytokinin riboside 5'-monophosphate phosphoribohydrolase Proteins 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 210000001938 protoplast Anatomy 0.000 description 5
- 150000008223 ribosides Chemical class 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 241000701489 Cauliflower mosaic virus Species 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 210000004102 animal cell Anatomy 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 238000004811 liquid chromatography Methods 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 239000002777 nucleoside Substances 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 3
- 101100343605 Arabidopsis thaliana LOG1 gene Proteins 0.000 description 3
- 101100343607 Arabidopsis thaliana LOG3 gene Proteins 0.000 description 3
- 101100343608 Arabidopsis thaliana LOG4 gene Proteins 0.000 description 3
- 229930192334 Auxin Natural products 0.000 description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000723873 Tobacco mosaic virus Species 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
- 239000002363 auxin Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008722 morphological abnormality Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 150000003833 nucleoside derivatives Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000005648 plant growth regulator Substances 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- -1 tin riboside Chemical class 0.000 description 3
- 108700026220 vif Genes Proteins 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- 101150101112 7 gene Proteins 0.000 description 2
- 108090000104 Actin-related protein 3 Proteins 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 101100343609 Arabidopsis thaliana LOG5 gene Proteins 0.000 description 2
- 101100343610 Arabidopsis thaliana LOG6 gene Proteins 0.000 description 2
- 101100343611 Arabidopsis thaliana LOG7 gene Proteins 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XXFACTAYGKKOQB-SSDOTTSWSA-N Dihydrozeatin Natural products OC[C@H](C)CCNC1=NC=NC2=C1NC=N2 XXFACTAYGKKOQB-SSDOTTSWSA-N 0.000 description 2
- DBVVQDGIJAUEAZ-YXYADJKSSA-N Dihydrozeatin riboside Chemical compound C1=NC=2C(NCCC(CO)C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O DBVVQDGIJAUEAZ-YXYADJKSSA-N 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- XXFACTAYGKKOQB-ZETCQYMHSA-N dihydrozeatin Chemical compound OC[C@@H](C)CCNC1=NC=NC2=C1NC=N2 XXFACTAYGKKOQB-ZETCQYMHSA-N 0.000 description 2
- DBVVQDGIJAUEAZ-UHFFFAOYSA-N dihydrozeatin riboside Natural products C1=NC=2C(NCCC(CO)C)=NC=NC=2N1C1OC(CO)C(O)C1O DBVVQDGIJAUEAZ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000005059 dormancy Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000010230 functional analysis Methods 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000003375 plant hormone Substances 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 239000012521 purified sample Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 2
- GOSWTRUMMSCNCW-UHFFFAOYSA-N trans-zeatin riboside Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1OC(CO)C(O)C1O GOSWTRUMMSCNCW-UHFFFAOYSA-N 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229940023877 zeatin Drugs 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 101100163849 Arabidopsis thaliana ARS1 gene Proteins 0.000 description 1
- 101100343612 Arabidopsis thaliana LOG8 gene Proteins 0.000 description 1
- 101100343613 Arabidopsis thaliana LOG9 gene Proteins 0.000 description 1
- 101100007857 Bacillus subtilis (strain 168) cspB gene Proteins 0.000 description 1
- 241000702286 Bean golden mosaic virus Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 101710166534 Cytokinin dehydrogenase 2 Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102100034866 Kallikrein-6 Human genes 0.000 description 1
- 238000012218 Kunkel's method Methods 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- DIWRORZWFLOCLC-UHFFFAOYSA-N Lorazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-UHFFFAOYSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 239000006391 Luria-Bertani Medium Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 102000010722 N-Glycosyl Hydrolases Human genes 0.000 description 1
- 108010063372 N-Glycosyl Hydrolases Proteins 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101100399514 Oryza sativa subsp. japonica LOG gene Proteins 0.000 description 1
- 101100399507 Oryza sativa subsp. japonica LOGL4 gene Proteins 0.000 description 1
- 101100399512 Oryza sativa subsp. japonica LOGL9 gene Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Chemical class 0.000 description 1
- 108010080698 Peptones Chemical class 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241001417524 Pomacanthidae Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 101100097319 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ala1 gene Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001415850 Strigidae Species 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000011681 asexual reproduction Effects 0.000 description 1
- 238000013465 asexual reproduction Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 101150110403 cspA gene Proteins 0.000 description 1
- 101150068339 cspLA gene Proteins 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 108010088245 cytokinin oxidase Proteins 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 101150109949 endou gene Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000014634 leaf senescence Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical class [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 229940066528 trichloroacetate Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8291—Hormone-influenced development
- C12N15/8295—Cytokinins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present invention relates to utilization of an active cytokinin synthase gene. More specifically, the present invention relates to a method for producing a transformed plant using an enzyme gene having an activity of catalyzing a synthesis reaction of active cytokinin from nucleotide-type cytokinin.
- Cytokinin is a very important plant honolemon that has various physiological activities such as promotion of cell division, cell cycle node, prevention of aging, and activation of buds, and controls the quantitative productivity of crops.
- the basic skeleton of cytokinin has a structure with a 5 carbon prenyl group at the 6-position nitrogen atom of adenine.
- tZ transzeatin
- iP isopentenyl adenine
- base base
- nucleotide-type cytokinins are produced by the condensation reaction of adenine nucleotides and dimethylallylphosphoric acid (DMAPP).
- This nucleotide body has no activity as a cytokinin, but after that, in the second reaction, it becomes a nucleoside-type cytokinin by phosphatase, and ribose is removed by the action of nucleosidase, and the active cytokinin of the base is released. It is converted into a molecule-(Non-patent F Reference 1, Review: Sakakibara, H. (2006) Cytokinins: Activity, biosynthesis and translocation. Annu. Rev. Plant Biol. 57: 431-449.).
- Non-patent Document 2 Werner T, Motyka V, Strnad M, Schmulling T. (2001) Regulation of plant growth by cytokinin. Proc Natl Acad Sci USA 98: 10487-10492.
- Non-patent literature 3 Ashikari, M., Sakakibara, H., Lin, S.-Y., Yamaraoto, T., Takashi, T., Nishimura, A., Angeles, ER, Qian, Q., Kitano, H. and atsuoka, M. (2005) Cytokinin oxidase regulates rice grain production, Science, 309: 741- 745)), there is no technology to directly control the amount of active cytokinin synthesis.
- Non-Patent Document 4 Zubko E, Adams CJ, Machaekova I, Malbeck J, Scol lan C, Meyer P. 2002.
- Activation tagging identifies a gene from Petunia hybrida respons ible for the product ion of act ive cytokinins in plants. Plant J. 29: 797-808.
- an object of the present invention is to elucidate an enzyme gene that can directly control the amount of active cytokinin synthesis, and to provide a transformed plant in which the amount of cytokinin is regulated using the gene.
- the present inventors conducted a structural and functional analysis focusing on genes expressed in rice shoot apical meristems. Although it was an enzyme gene that was predicted to be involved in lysine decarboxylation in the database, it was not lysine decarboxylase activity, but a reaction that synthesizes active cytokinin from nucleotide-type cytokinin (cytokinin activation reaction). It has been newly found that it has an activity of catalyzing. Moreover, it is assumed that the process will proceed in two stages. It was also found that the enzyme gene is carried out in one step for the cytokinin activation reaction.
- the present invention has been completed based on such findings.
- the present invention includes the following inventions.
- a recombinant vector comprising any of the following genes (a) to (d):
- Amino represented by any one of SEQ ID NOs: 2, 4, 6, 8, 1 0, 1 2, 14 and 16 It encodes a protein consisting of an amino acid sequence in which one or several amino acids have been deleted, substituted or added in the acid sequence, and having an activity of catalyzing the synthesis of an active cytokinin from a nucleotide type cytokinin Gene ''
- Any one of the following genes (a) to (d) or the recombinant vector described in (4) is introduced into a plant cell, and the plant body is regenerated from the plant cell. How to create convertible plants.
- SEQ ID NO: 1, 3, 5, 7, 9, 1 1, 1 3, or 15 A gene consisting of DNA that encodes a protein that is activated and catalyzes the synthesis reaction of active cytokinin from nucleotide-type cytokinin.
- a method for regulating the amount of active cytokinin in a plant comprising controlling the expression level of any of the following genes (a) to (d) in the plant.
- SEQ ID NO: 1, 3, 5, 7, 9, 1 1, 1 3, or 15 A gene consisting of DNA that encodes a protein that is hybridized and has an activity of catalyzing the synthesis of active cytokinin from nucleotide-type cytokinin
- the transformant according to (1) is cultured in a medium supplemented with nucleotide-type cytokinin as a substrate, and active cytokinin is collected from the culture. Production method.
- SEQ ID NOS: 1, 3, 5, 7, 9, 11, 1, 13, and .15 A gene consisting of DNA that encodes a protein that is activated and catalyzes the synthesis reaction of active cytokinin from nucleotide-type cytokinin.
- Fig. 1 shows an electrophoretogram of the purified LOG protein preparation (lane 1: molecular size marker, lane 2: purified preparation of LOG protein (3 / z g protein).
- Figure 2A shows the chromatogram of each substrate preparation mixture
- Figure 2B shows iPRMP.
- FIG. 2 C shows tZRMP
- Fig. 2 D shows chromatograms of each reaction product when reacted with purified LOG protein using tZ as a substrate (upper: substrate only, lower: Reaction product).
- Figure 3 shows the chromatogram of (A) cadaverine preparation, (B) reaction product chromatogram when reacted with purified LOG protein using L-lysine as substrate ((B) -1: Substrate only, (B) _2: reaction product).
- FIG. 4 shows the substrate specificity of the LOG protein (the activity when each compound was reacted under the same conditions with the activity when iPRMP was used as a substrate as 1 was shown as a relative value).
- Figure 5 shows the reaction formula for the synthesis of active cytokinin from nucleotide-type cytokinin by LOG protein.
- Fig. 6 shows the results of SDS polyacrylamide electrophoresis of purified AtLOGl, 2, 3, 4, 5, 7, and 8 proteins (leftmost lane: molecular weight marker, each lane: molecular weight 31).
- a band seen around kDa is a band derived from each AtLOG protein).
- Figure 7 shows the substrate specificity of AtLOGl, 2, 3, 4, 5, 7, and 8 proteins (activity when each compound is reacted under the same conditions, with 100% activity when iPRMP is used as a substrate) (Error bars indicate standard deviations calculated based on the results of three reactions under the same conditions).
- Fig. 8 shows the semiquantitative RT-PCR analysis results of AtL0G4 and 7 genes in 35S :: AtL0G4, 35S :: AtL0G7 transfectants.
- Figure 9 shows the abnormalities of rosette leaves in the three :: AtL0G7 transformants.
- 35S :: AtL0G7 strain # 6; T1 generation
- transformant rosette leaves were observed with a stereomicroscope (scale: 1 mm).
- FIG. 10 shows an abnormality of rosette leaves observed in 35S :: AtL0G4 transformants.
- 35S :: AtL0G4 transformants One month and a half after germination and 35S :: AtL0G4 (strain # 26; T1 generation) Transformant rosette leaves were decolorized and fixed with 70% ethanol and then observed with a stereomicroscope (scale is 0.5 on the left side) cm, the right side is 2 cm).
- Fig. 11 shows vascular morphological abnormalities observed in 35S :: AtL0G7 transformants.
- 35S :: AtL0G7 strain # 26; T2 generation
- Figure 12 shows the delayed leaf senescence seen in 35S :: AtL0G4 transformants. 70 days after germination with wild type and 35S:: AtL0G4 (strain # 6; T1 generation) 'transformant rosette leaves (1 cm).
- Figure 13 shows the promotion of lateral bud formation seen in 35S :: AtL0G4 transformants. Wild-type and 35S:: AtL0G4 (strain # 13; T2 generation) 3 weeks after germination The above-ground part of the transformant was observed with a stereomicroscope (arrow: extracted flower stem, triangle: developed side bud, scale is 1 ⁇ ).
- Fig. 14 shows the inflorescence abnormality observed in 35S :: AtL0G7 transformants. Inflorescence (scale: 1 cm) of wild type and 35S:: AtL0G7 (strain # 6; T1 generation) 3 weeks after germination.
- FIG. 15 shows the increase in seed size seen in 35S :: AtL0G4 transformants. Wild-type and 35S:: AtL0G4 (strain # 26; T2 generation) seeds were observed with a stereomicroscope (scale is 1 cm on the left and 0.2 mm on the right).
- Figure 16 shows the increase in seed weight seen in 35S :: AtL0G7 transformants.
- 35S For wild type and 35S:: AtL0G7 (strain # 6; T2 generation), weighed 100 seeds and calculated the weight per grain. Error bars indicate standard deviations calculated based on results obtained from three different seed pools.
- the present invention relates to the use of a gene encoding an enzyme protein having an activity of catalyzing a synthetic reaction of active cytokinin from nucleotide-type cytokinin.
- the gene encoding an enzyme protein having an activity of catalyzing the synthesis reaction of active cytokinin from nucleotide-type cytokinin (hereinafter referred to as “L0G gene”) is a gene consisting of DNA having the base sequence shown in SEQ ID NO: 1.
- the sequence information of the LOG gene has already been reported in the international nucleotide sequence database (Accession number: AK071695) (nucleotide); BAD52880 (protein); Tigr locus: L0C_0s01g40630; RAP locus: 0s01g0588900).
- the function of the protein consisting of mino acid was predicted to be lysine decarboxylase on the NCBI database (http://www.ncbi.nlm.nih.gov).
- the present inventors expressed the LOG gene in an undifferentiated cell group called stem cells at the tip of rice shoot apical meristem and its surrounding tissues, there is a possibility that the LOG gene may be involved in maintaining stem length meristem.
- the functional analysis was advanced, and it was found that there is an activity that catalyzes the synthesis reaction of the active cytokinin from the nucleotide-type cytokinin, not the lysine decarboxylase activity.
- the LOG gene used in the present invention lacks one or several amino acids in the amino acid sequence shown in SEQ ID NO: 2 as long as it retains the activity of catalyzing the synthesis reaction of active cytokinin from nucleotide-type cytokinin. It may be a gene encoding a protein comprising an amino acid sequence substituted or added.
- the number of amino acids that may be deleted, substituted or added is preferably 1 to several.
- 1 to 10, preferably 1 to 5 amino acids of the amino acid sequence shown in SEQ ID NO: 2 may be deleted, and 1 to 10, preferably 1 in the amino acid sequence shown in SEQ ID NO: 2.
- ⁇ 5 amino acids may be added, or 1 to 10, preferably 1 to 5 amino acids of the amino acid sequence shown in SEQ ID NO: 2 may be substituted with other amino acids, .
- the LOG gene used in the present invention is a gene having 80% or more homology with the amino acid sequence shown in SEQ ID NO: 2, and has an activity of catalyzing the synthesis reaction of active cytokinin from nucleotide-type cytokinin. It may be a gene that encodes a protein that it has.
- the above-mentioned homology of 80% or more refers to homology of preferably 90% or more, more preferably 95% or more.
- activity that catalyzes the synthesis reaction of active cytokinin from nucleotide-type cytokinin refers to a reaction that removes ribose 5 '-phosphate from nucleotide-type cytokinin and synthesizes active cytokinin of the base.
- Catalytic activity La.
- nucleotide-type cytokinin includes isopentenyl adenine difoside, 5 — “zinoic acid (i sorpenyladenine riboside o-monophosphate: iPRMP), trans-zeatin riboside 5 ′-phosphoric acid (trans-zeatin ribos ide 5 '-monophosphate: tZRMP), dihydrozeatin ribos ide t> -monophosphate:.
- DZRMP cis-se, tin riboside 5' -monophosphate (Ci s-zeat in riboside 5'-monophosphate (cZRMP)) is included, and the active cytokinin is a dephosphorylated 5 '-phosphonic acid penicillin.
- Adenine N 6- (delta-2-i sopentenyl) adenine (iP), ⁇ -lance-zeatin (tZ), dihydrozeatin (DZ), cis-zeatin (ci s-zeatin) : CZ
- iP delta-2-i sopentenyl
- tZ ⁇ -lance-zeatin
- DZ dihydrozeatin
- Ci s-zeatin cis-zeatin
- “having an activity of catalyzing a synthesis reaction of an active cytokinin from a nucleotide-type cytokinin” means that the above activity is substantially equivalent to the activity of the protein having the amino acid sequence shown in SEQ ID NO: 2. Say something.
- the LOG gene according to the present invention hybridizes under stringent conditions with a DNA consisting of a base sequence complementary to the DNA consisting of the base sequence shown in SEQ ID NO: 1, and from the nucleotide type cytokinin to the active type cytokinin. It may be a gene consisting of DNA that encodes a protein having an activity that catalyzes a synthesis reaction.
- the stringent end condition means a condition in which a so-called specific hybrid is formed and a non-specific hybrid is not formed.
- a nucleic acid having high homology that is, a complementary strand of DNA consisting of a base sequence having a homology of 80% or more, preferably 90% or more, more preferably 95% or more with the base sequence represented by SEQ ID NO: 1 hybridizes.
- a condition in which a complementary strand of a nucleic acid having a lower homology is not hyper-predated is mentioned.
- the sodium salt concentration is 15 to 750 raM, preferably 50 to 750 mM, more preferably 300 to 750 mM, and the temperature is 25 to 70 ° C, preferably 50 to 70 ° C, more preferably 55 to 65 °. C, the formamide concentration is 0 to 50%, preferably 20 to 50%, more preferably 35 to 45%.
- the filter wash conditions after hybridization are usually the sodium salt concentration. Is 15 to 600 mM, preferably 50 to 600 mM, more preferably 300 to 600 ra, and the temperature is 50 to 70 ° C, preferably 55 to 70 ° C, more preferably 60 to 65 ° C.
- the LOG gene used in the present invention is obtained by performing PCR amplification using a primer designed based on the sequence of SEQ ID NO: 1 or 2, using a nucleic acid derived from one cDNA library or one genomic DNA library as a cage, for example. It can be obtained as a nucleic acid fragment.
- the LOG gene can be obtained as a nucleic acid fragment by performing hybridization using a nucleic acid derived from the above-mentioned library etc. as a cage and using a DNA fragment that is a part of the LOG gene as a probe.
- the LOG gene may be synthesized as a nucleic acid fragment by various nucleic acid sequence synthesis methods known in the art such as chemical synthesis methods.
- the amino acid deletion, addition, and substitution can be performed by modifying the gene encoding the protein by a technique known in the art. Mutation can be introduced into a gene by a known method such as the Kunkel method or the Gapped duplex method or a method equivalent thereto, for example, a mutation introduction kit (for example, Mutant_K ( Mutations are introduced using TAKARA) or Mutant-G (TAKARA)), or using the TAKARA LA PCR in vitro Mutagenesis series kit.
- a mutation introduction kit for example, Mutant_K ( Mutations are introduced using TAKARA) or Mutant-G (TAKARA)
- TAKARA LA TAKARA LA PCR in vitro Mutagenesis series kit.
- Examples of the LOG gene that can be used in the present invention include the following gene groups that are expected to belong to the same gene family as the above-mentioned LOG gene (Accession number: AK071695).
- At5g06300 and At5gl l950 Seven genes of At5g06300 and At5gl l950 are the Shiroinazuna LOG homologue genes (AtLOGl, 2, 3, 4, 5, 7, 8) that encode amino acid sequences having high homology to the amino acid sequence of the rice LOG protein. Respectively). As shown in the examples described later, these cynomolgus LOG homologue genes have the activity of catalyzing the synthesis of active cytokinin from nucleotide-type cytokinin in the same manner as the above-mentioned LOG protein, and In the overexpressing body, trait changes such as the promotion of lateral bud elongation based on an increase in the amount of active cytokinin synthesis were observed. AtLOGl, 2, 3, 4,
- the base sequences of the 5, 7, and 8 genes are shown in SEQ ID NOs: 3, 5, 7, 9, 11, 1, 1, 3, and 15 respectively.
- SEQ ID NOs: 4, 6, 8, 10, and 12 , 14 and 16 encode the amino acid sequences shown respectively.
- these Arabidopsis LOG homologue genes are also synthesized from nucleotide-type cytokinins. As long as it has an activity that catalyzes, these mutant genes may be used, and the sequence homology range, amino acid deletion, substitution, and addition number range are as described above.
- the recombinant vector of the present invention used for plant transformation can be constructed by introducing the above LOG gene into an appropriate vector.
- a vector for example, pBI, pPZP, and pSMA vectors that can introduce a target gene into a plant via agrobacterium are preferably used.
- pBI binary vectors or intermediate vector systems are preferably used, and examples thereof include pBI121, pBI101, ⁇ .2, ⁇ .3, and the like.
- a binary vector is a shuttle vector that can replicate in Escherichia coli (Escheric hia col i) and agrobacterium, and when the plant is infected with agrobacterium, which holds the binary vector, the LB and RB sequences on the vector It is possible to incorporate the DNA surrounded by the border sequence consisting of the plant nucleus DNA.
- a pUC vector can directly introduce a gene into a plant, and examples thereof include pUC18, pUC19, and pUC9.
- plant virus vectors such as force reflower mo I virus (CaMV), kidney bean mosaic virus (BGMV), tobacco mosaic virus (TMV) and the like can be used.
- the target gene is inserted between the boundary sequences (LB, RB) of the above binary vector, and this recombinant vector is amplified in E. coli.
- the amplified recombinant vector is introduced into Agrobacterium cumefaciens C58, LBA4404, EHA101, EHA105, Agrobacterium rhizogenes L BA1334, etc. by electroporation, etc., and the Agrobacterium Is used for transduction of plants.
- the purified DNA is cleaved with a suitable restriction enzyme, inserted into a suitable vector DNA restriction enzyme site or a multiple cloning site, and ligated to the vector.
- a suitable restriction enzyme inserted into a suitable vector DNA restriction enzyme site or a multiple cloning site, and ligated to the vector.
- the target gene must be incorporated into a vector so that the function of the gene is exhibited. Therefore, the vector contains a promoter, enhancer, terminator, binary vector upstream, inside, or downstream of the target gene.
- Replication origins eg, replication origins derived from Ti or Ri plasmids
- selection marker genes, etc. can be linked.
- a “promoter” does not have to be derived from a plant as long as it functions in plant cells and can induce expression in a specific tissue of a plant or at a specific developmental stage.
- Specific examples include rice LOG gene promoter, cauliflower mosaic virus (CaMV) 35S promoter, nopaline synthase gene promoter (Pnos), maize-derived ubiquitin promoter, rice-derived actin promoter, tobacco-derived PR Examples include protein promoters.
- enhancer examples include an enhancer region that is used to increase the expression efficiency of the target gene and includes an upstream sequence in the CaMV35S promoter. '
- the terminator can be any sequence that can terminate the transcription of the gene transcribed by the promoter.
- the terminator of the nopaline synthase (N0S) gene the terminator of the octvin synthase (0CS) gene, CaMV Examples include the 35S RNA gene terminator.
- selection marker gene examples include an ampicillin resistance gene, a neomycin resistance gene, a hygromycin resistance gene, a bialaphos resistance gene, and a dihydrofolate reductase gene.
- the selection marker gene may be ligated to the same plasmid together with the target gene as described above, or a recombinant vector may be prepared.
- a recombination obtained by ligating the selection marker gene to the plasmid may be prepared separately. If prepared separately, cotransfect each vector with the host.
- the transformed plant of the present invention can be produced by introducing the above gene or recombinant vector into the target plant.
- gene introduction means that a target gene is released into the cells of the host plant by, for example, a known genetic engineering technique. It means introducing in a form that is possible.
- the gene introduced here may be integrated into the genomic DNA of the host plant or may be present as it is contained in the foreign vector.
- the agrobacterium method As a method for introducing the gene or the recombinant vector into a plant, various methods already reported and established can be used as appropriate.
- the agrobacterium method, the PEG-calcium phosphate method, the electric mouth Examples include the position method, the liposome method, the particle gun method, and the microinjection method.
- the agrobacterium method protoplasts are used, tissue pieces are used, and plants themselves are used (in planta method).
- agrobacterium with Ti or Ri plasmid Agrobacterium tumefaciens or Agrobacterium rhizogenes, respectively
- fusion with spheroplastized agrobacterium In the case of using a tissue piece, it can be carried out by infecting a sterile cultured leaf piece (leaf disc) of the target plant or infecting a callus (undifferentiated cultured cell).
- agropacteria directly applied to water-absorbing seeds, seedlings (plant seedlings), potted plants, etc.
- telomere length is a region of DNA that has been incorporated into a plant.
- DNA is prepared from transformed plants and PCR is performed by designing LOG gene-specific primers. After PCR, the amplified product is subjected to agarose gel electrophoresis, polyacrylamide gel electrophoresis, or capillary electrophoresis, etc., stained with bromide zyme, SYBR Green solution, etc., and one amplified product. By detecting this as a band, transformation can be confirmed.
- amplification products can be detected by PCR using primers previously labeled with a fluorescent dye or the like.
- the amplification product may be bound to and the amplification product confirmed by fluorescence or enzymatic reaction.
- protein extracted from the plant cell, fractionated by two-dimensional electrophoresis, and the LOG gene introduced into the plant cell is expressed by detecting the protein band encoded by the LOG gene. That is, it may be confirmed that the plant has been transformed. Subsequently, the N-terminal amino acid sequence of the detected protein is determined by Edman degradation and the like, and the plant cell transformation is further verified by confirming whether it matches the N-terminal sequence of SEQ ID NO: 2. can do.
- target genes such as various reporter genes such as beta glucuronidase (GUS), luciferase (LUC) x Green fluorescent protein (GFP), chloramphenicol lucetyl transferase (CAT), beta galactosidase (LacZ), etc.
- GUS beta glucuronidase
- LOC luciferase
- GFP Green fluorescent protein
- CAT chloramphenicol lucetyl transferase
- LacZ beta galactosidase
- the plant used for transformation in the present invention may be either a monocotyledonous plant or a dicotyledonous plant, such as Brassicaceae (Arabidopsis thaliana, cabbage, rapeseed, etc.), Gramineae (rice, maize, barley, And so on), plants belonging to the solanaceous family (Tomato, eggplant, potato, tobacco, etc.), legumes (soybean, endou, green beans, etc.), etc., but are not limited to these plants.
- Brassicaceae Arabidopsis thaliana, cabbage, rapeseed, etc.
- Gramineae rice, maize, barley, And so on
- plants belonging to the solanaceous family Tomato, eggplant, potato, tobacco, etc.
- legumes sesybean, endou, green beans, etc.
- plant materials to be transformed include plant organs such as stems, leaves, seeds, embryos, ovules, ovary, shoot tips, plant tissues such as cocoons and pollen, and sections thereof, undifferentiated force It may be any of plant cultured cells such as lupus and proplasts from which cell walls have been removed by enzyme treatment. In the case of applying the in planta method, water-absorbing seeds or the whole plant can be used. .
- a transformed plant refers to the entire plant body, plant organs (eg leaves, petals, stems, roots, fruit seeds, seeds, etc.), plant tissues (eg epidermis, phloem, soft tissue, xylem, vascular bundles) Etc.), or plant cultured cells (for example, callus).
- plant organs eg leaves, petals, stems, roots, fruit seeds, seeds, etc.
- plant tissues eg epidermis, phloem, soft tissue, xylem, vascular bundles
- Etc. plant cultured cells
- an organ or an individual should be regenerated by a known tissue culture method. Yes.
- a method for regenerating plant cells from plant cells Regeneration from a plant cell to a plant body can be performed, for example, as follows.
- plant tissues or protoplasts are used as plant materials to be transformed, these are inorganic elements, vitamins, carbon sources, sugars as energy sources, plant growth regulators (auxin, cytokinin, gibberellins).
- plant growth regulators auxin, cytokinin, gibberellins.
- Plant hormones such as abscisic acid, ethylene, brassinosterolide, etc.
- force-loss induction a sterilized callus-forming medium to form dedifferentiated callus that grows indefinitely
- the callus thus formed is transferred to a new medium containing a plant growth regulator such as auxin and further propagated (passaged).
- redifferentiation induction organ redifferentiation
- induction of regeneration can be performed by appropriately setting the types and amounts of various components such as plant growth regulators such as auxin and carbon sources, light, temperature, etc. in the medium.
- plant growth regulators such as auxin and carbon sources, light, temperature, etc. in the medium.
- somatic embryos, adventitious roots, adventitious buds, adventitious foliage, etc. are formed and further grown into complete plants.
- it may be stored in a state before it becomes a complete plant (for example, encapsulated artificial seed, dried embryo, freeze-dried cell, tissue, etc.).
- the transformed plant of the present invention is a progeny plant obtained by sexual reproduction or asexual reproduction of a plant into which the gene has been introduced (including a plant regenerated from a transformed cell or a callus), and its It also includes some of the tissues and organs of the progeny plants (seed, protoplasts, etc.).
- the transformed plant of the present invention can be mass-produced by obtaining propagation materials such as seeds and protoplasts from a plant transformed by introducing the LOG gene, and cultivating or culturing them.
- the transformed plant is capable of, for example, promoting lateral bud elongation (inhibition of apical dominance), Promotion of germination, breaking of dormancy, promotion of cell division, promotion of chlorophyll synthesis, inhibition of senescence, promotion of fruit enlargement, increase in number of flower stems, formation of large seeds, formation of thick veins, delayed senescence of leaves, changes in inflorescence, etc. Will be accepted.
- the LOG gene is expressed in a limited region of the shoot apical meristem from previous research findings, and the number of rice grains is significantly reduced in the disrupted strain of this gene, and in the shoot apical meristem during the flower bud differentiation stage It has been suggested that there is a correlation between the cytokinin content and the number of grains. Therefore, rice transformed with the LOG gene expressed specifically in the shoot apical meristem can be expected to increase the grain size.
- the expression level of the LOG gene in plants can be controlled locally or globally, for example by the promoter used, the LOG promoter, the cytokininoxidase 2 (0sCKX2) promoter, the aging—inducible gene (SAG) promoter; (Promoting or suppressing) can regulate the amount of active cytokinin in the plant, and as a result, the growth and physiological actions of various plants involving cytokinin, such as the number of grains, side buds (buds) It is possible to regulate formation and elongation, aging, dormancy, falling fruit, cell cycle, photosynthesis, transpiration, etc.
- SAG aging—inducible gene
- the protein encoded by the LOG gene is obtained by transforming a host with a recombinant vector into which the gene has been introduced to obtain a transformant, culturing the transformant, and collecting the transformant from the culture.
- the “culture” means not only the culture supernatant but also any cultured cells or cultured cells, or crushed cells or cells.
- the recombinant vector may be any recombinant vector that can replicate in a host, such as plasmid DNA or phage DNA.
- plasmid DNA includes plasmids derived from E. coli (eg, pBR322, pBR325, pUC118, pUC119, pUC18, pUC19, pBluescript, etc.), plasmids derived from Bacillus subtilis (eg, pUB110, pTP5, etc.), and plasmids derived from yeast.
- retrovirus or vaccinia virus Insect virus vectors such as animal viruses and baculoviruses can also be used.
- the above vector contains a replication origin, a promoter, and a selection marker, and may contain an enhancer, a terminator, a ribosome binding site, a polyadenylation signal, and the like as necessary.
- E. coli vectors are derived from, for example, ColEl, R-factor, and F-factor
- yeast vectors are derived from, for example, 2 Aim DNA
- ARS1 and animal cell vectors are SV40, those derived from adenovirus are used.
- vectors for E. coli include trp promoter, lac promoter, PL promoter, PR promoter, cspA promoter, etc.
- yeast vectors include gal l promoter, PH05 promoter, PGK promoter, GAP promoter.
- a motor, ADH promoter, A0X1 promoter, etc., and animal cell vectors such as SRa promoter, SV40 promoter, LTR promoter, CMV promoter, etc. are used.
- vectors for E. coli include kanamycin resistance gene, ampicillin resistance gene, tetracytalin resistance gene, etc.
- yeast vectors include Leu2, Trpl, Ura3 genes, etc.
- animal cell vectors include Neomycin resistance gene, thymidine kinase gene, dihydrofolate reductase gene, etc. are used.
- prokaryotic or eukaryotic organisms can be used as the host.
- Prokaryotes include bacteria belonging to the genus Escherichia such as Escherichia coli, the genus Chanininos such as Bacillus subtilis, and the genus Pseudomonas such as Pseudomonas putida.
- Eukaryotic organisms include yeasts such as Saccharomyces cerevisiae and Schizosaccharotnyces pombe; animal cells such as COS cells, CH0 cells, Vero and C123 cells, or Sf9 And insect cells such as SF12.
- yeasts such as Saccharomyces cerevisiae and Schizosaccharotnyces pombe
- animal cells such as COS cells, CH0 cells, Vero and C123 cells, or Sf9 And insect cells such as SF12.
- a medium for cultivating transformants obtained using microorganisms such as E. coli and yeast as a host contains a carbon source, a nitrogen source, inorganic salts, etc. that can be assimilated by the microorganism, so that the transformant can be cultured efficiently. Any medium that can be used, natural medium, synthetic medium Any of these may be used.
- Examples of the carbon source include carbohydrates such as glucose, fructose, sucrose, and starch, organic acids such as vinegar and propionic acid, and alcohols such as ethanol and propanol.
- Nitrogen sources include ammonia, ammonium chloride, ammonium sulfate, ammonium acetate, ammonium salts of organic acids and other nitrogen-containing compounds, as well as peptone, meat extract, corn steep liquor, etc. Is mentioned.
- Examples of inorganic substances include potassium phosphate, potassium phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate, and calcium carbonate.
- the culture is usually carried out under aerobic conditions such as shaking culture or aeration and agitation culture, for example, at 25 to 35 ° C. for about 12 to 48 hours.
- the pH is adjusted using an inorganic or organic acid or an alkaline solution.
- an antibiotic such as ampicillin or tetracycline may be added to the medium as necessary.
- the target protein When the target protein is produced in the cells or cells after culturing, the target protein is collected by crushing the cells or cells by ultrasonic treatment, repeated freezing and thawing, homogenizer treatment, etc. When the target protein is produced outside the cells or cells, use the culture solution as it is, or remove the cells or cells by centrifugation or the like. Then, by using general biochemical methods used for protein isolation and purification, such as ammonium sulfate precipitation, gel chromatography, ion exchange chromatography, affinity chromatography, etc. alone or in appropriate combination, The target protein can be isolated and purified from the culture.
- a nucleotide-type cytokinin is added to the medium as a substrate so that it is active in the culture.
- Type cytokinin can be synthesized.
- the nucleotide-type cytokinin used as the substrate is as described above.
- the transformation is first performed by preculture. It is preferable to carry out the culture by activating the recombinant and inoculating it into the main culture medium for production of active cytokinin.
- the substrate content in the pre-culture medium and the main culture medium is about 0.1 to 1.0% in terms of solid content in the medium.
- the amount of the transformant used in the medium is, for example, about 1 to 100 mg per 1 L of the culture medium when inoculated with bacterial cells, and may be appropriately increased or decreased depending on the substrate content.
- the total amount of the substrate may be added at the start of the culture, or may be added continuously or intermittently during the culture.
- the produced active cytokinin may be taken out after completion of the culture, or may be taken out continuously or intermittently during the culture.
- Culturing is terminated when the desired amount of active cytokinin produced in the culture reaches a maximum.
- the active cytokinin in the culture solution is purified from the culture solution by a conventional method after completion of the culture. Purification may be performed by appropriately combining well-known means usually used in the technical field, for example, filtration, centrifugation, ion exchange or adsorption chromatography, solvent extraction, and the like as necessary. Best Mode for Carrying Out the Invention
- the LOG gene (Access ion number: AK071695 (nucleotide); BAD52880 (protein); Tigr locus: L0C_0s01g40630; RAP locus: 0s01g0588900) is predicted to encode a protein consisting of 242 amino acids. On the base (http://www.ncbi.nlm.nih.gov), its function was predicted as lysine decarboxylase.
- a gene with homology to the LOG gene is located on the Rhodococcus fasciens fas locus "Agrobacterium rhizogenes Ri puffs ⁇ (close to the isopentenyltransferase (IPT) that catalyzes the initial reaction of cytokinin biosynthesis. Therefore, the following experiment was conducted to examine the function of the LOG protein.
- coli colony was cultured overnight at 37 ° C in Luria-Bertani medium containing 50 / ig / mL ampicillin and 20 / zg / mL chloramphenicol, and then 30mL of the overnight culture was added to 100 / g / mL ampicillin, 20 / Modified M9 medium containing xg / mL cucumber lamphenic acid and lng / mL tetracycline (M9 salt, 1M sorbitol, 1% casaraino acid, 2% sucrose, ImM MgS0 4 , 0.
- M9 salt 1M sorbitol, 1% casaraino acid, 2% sucrose, ImM MgS0 4 , 0.
- IraM CaCl 2 10 g / mL thiamine-
- Protein extraction from E. coli and LOG protein purification with nickel NTA superflo resin were performed as follows. First, E. coli pellets were suspended in 6 mL of Lys is buffer [50raM NaHP0 4 , 300 mM NaCl, lOraM imidazole, ImM MgCl 2 , 0.5 mM dithiothreitol (DTT), pH 8.0], and protease inhibitor cocktai l (X100, Signia ⁇ OL and 6mg lysozyme chloride were added and left on ice for 30 minutes, and then E. coli cells were destroyed with an ultrasonic disrupter (Tytec), using microchips, 20 seconds x 8 times, Duty cycle 50%, output 5.
- Lys is buffer 50raM NaHP0 4 , 300 mM NaCl, lOraM imidazole, ImM MgCl 2 , 0.5 mM dithiothreitol (DTT), pH
- Recombinant LOG protein 3 / ig obtained in Example 1 was used as a substrate for various cytokinins. As a response.
- the site cytokines used were N 6- (delta-2-isopentenyl) adenine (iP), trans-zeatin (tZ), cis-zeatin C), iP riboside (iPR), tZ riboside. (tiR), cZ riboside vcz, R), iPR 5'-monophosphate (iPRMP), tZR 5'-monophosphate (tZRMP).
- the reaction conditions were 50ra Tris-HCl, lraM MgCl 2 , 50 / zM substrate, pH7, incubation at 30 ° C for 2 hours, and the reaction volume was 100 // L. 20 ° /.
- the reaction was stopped by adding 10 // L of acetic acid, centrifuged at 15,000 rpm for 20 minutes at room temperature, and the supernatant 20 // L was analyzed by liquid chromatography using HPLC (Waters Alliance 2695 / PDA detector 2996).
- the column used was Sy ⁇ etry C18, 3.5 ⁇ m, 2.1X100 mm cartridge (Waters). Elution was performed using solvent C (100% acetonitrile) and solvent D (2% acetic acid).
- the elution conditions and solvent concentration gradient program are shown in Table 1 below.
- LOG protein was previously expected to be lysine decarboxylase, we examined whether it was reactive with lysine.
- Recombinant LOG protein 3 g was added at 40 ° C, 60 ° C in a reaction solution 100 / zL consisting of 500 mM sodium acetate buffer, H 6.0, 5 mL—lysine Incubated for minutes.
- 34 // L of 20% trichloroacetate was added, centrifuged at 10,000g for 20 minutes, and then benzoylated using 100 // L of the supernatant.
- the specific operation is as follows. 2N NaOH was added to 100 / L of the reaction solution, L of benzoyl chloride was further added, and the mixture was allowed to stand at room temperature for 20 minutes.
- Substrate and reaction products were monitored by 226 nra absorption. Since the purified substance produced by lysine decarboxylase is expected to be cadaverine, the cadaverine preparation lrnnol was separately injected to determine the elution time of the reaction product. As shown in Figure 3, the LOG protein did not show any reactivity to lysine. Therefore, it was judged that it does not have the function as lysine decarboxylase expected in the database.
- Example 4 Examination of presence or absence of substrate specificity for nucleotide-type cytokinin bodies The anti-specificity of LOG protein to nucleotide-type cytokinin bodies was examined. At the same time, the presence or absence of reactivity to AMP was also examined.
- iPRMP, tZR P, dihydrozeatin riboside 5 '-monophosphate (DZRMP), cZR Seven types of 5'-monophosphate (cZRMP), iPR '5'-diphosphate (iPRDP), iPR 5'-triphosphate (iPRTP), and AMP were used as follows.
- LOG protein uses cytokinin nucleoside 5, monophosphate such as tZRMP, DZRP, and cZRMP in addition to iPRMP. However, it did not show any reactivity to AMP, iPRDP, or iPRTP.
- LOG protein is predicted to function as a lysine decarboxylase in the database, the LOG protein actually removes ribose 5 ′-phosphate from the nucleotide-type cytokinin, and the active protein of the base. It was found to be an enzyme that catalyzes a completely new reaction that produces tokainin. Figure 5 shows the reaction catalyzed by the LOG protein. From the above results, it is concluded that LOG protein is suitable as a name for cytokinin nucleoside 5'-monophosphate phosphoribohydrolase.
- Example 6 Isolation of Arabidopsis LOG Homolog Gene (AtLOGs) cDNA
- Arabidopsis thaliana has a cytokinin-activating enzyme with the same function as LOG protein.
- a survey was conducted. First, search for homologous genes in Arabidopsis by performing a prote in BLAST search based on the amino acid sequence of the LOG protein in the NCBI database (http://www.ncbi.nlm.nih.gov/). did.
- Arabidopsis genes AtL0Gl-9 Arabidopsis thaliana LOG 1-9; Table 3
- the enzyme activity of the purified AtLOG protein was evaluated under the same reaction conditions as in Example 2.
- cytokinin nucleosides such as iPRMP, tZRMP, DZRMP, and cZRMP were used as the substrate. Became clear (Fig. 7). Similar to LOG protein, it showed little reactivity to AMP, iPRDP, and iPRTP.
- the enzyme characteristics of each AtLOG protein for iPRMP were determined in the same manner as in Example 5 (Table 4).
- the K m , V max , and k cat values were calculated based on the reaction at the optimum pH for each AtLOG protein. Soil indicates the standard deviation calculated based on the results of three runs under the same conditions. Table 4
- the collected seeds were sown in MS medium containing 50 ng / ml kanamycin.
- individuals exhibiting kanamycin resistance were selected.
- 26 kanamycin-resistant lines (hereinafter referred to as 35S:: AtL0G4, 35S :: AtLOG7) that were successfully transfected were selected for each 26 lines.
- the selected T1 generation 35S:: AtL0G4 and 35S :: AtL0G7 transformants showed similar phenotypes.
- Tl generation 35S:: AtL0G4 (lines # 6, # 26), 35S:: AtL0G7 (lines # 3, # 26) extracted from rosette leaves Semi-quantitative RT-PCR analysis was performed using primers for amplification of the AtL0G4, 7 gene and Actin2 gene. As a control, cDNA (WT) derived from wild-type rosette leaves was used. The RT-PCR reaction was performed with 25 cycles of AtL0G4 and 35 cycles of Actin2 and AtL0G7. As a result, overexpression of AtL0G4 and AtL0G7 genes was confirmed in each of the two lines of plants (Fig. 8).
- the 35S :: AtL0G4 and 35S:: AtL0G7 transformants showed similar phenotypes, and it was confirmed that the phenotype was inherited from the T1 generation to the T2 generation.
- 35S :: AtL0G4, 35S:: AtL0G7 Transformants do not show any particular morphological abnormality with wild type until around 1 week after germination, but from around 2 weeks after germination where many rosette leaves are formed and developed. A remarkable form of abnormality was observed.
- the 35S :: AtL0G4, 35S :: AtL0G7 transformants formed deep green rose leaves along the veins (FIG. 9).
- a rice gene which has been previously encoded as a gene encoding lysine decarboxylase protein, is synthesized from a nucleotide-type cytokinin in the cytokinin biosynthetic pathway (an activation reaction of cytokinin). It was newly elucidated that it has a function of catalyzing the reaction. Therefore, the amount of active cytokinin (base) can be controlled directly by using this gene, which was previously only possible by modifying the degradation reaction of site power sinin. become.
- trait changes such as an increase in the number of flower stems, formation of large seeds, formation of thick leaf veins, and changes in inflorescence were observed, resulting in increased yields of crops, cut flowers, ornamental plants, etc. Expected to improve product value by diversifying expression traits.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/281,238 US8124834B2 (en) | 2006-09-04 | 2007-09-04 | Use of active cytokinin synthase gene |
JP2008533219A JPWO2008029942A1 (ja) | 2006-09-04 | 2007-09-04 | 活性型サイトカイニン合成酵素遺伝子の利用 |
EP07806990A EP2067859A4 (en) | 2006-09-04 | 2007-09-04 | USE OF AN ACTIVATED CYTOKININ BIOSYNTHETIZING ENZYME |
US13/349,889 US8962920B2 (en) | 2006-09-04 | 2012-01-13 | Use of active cytokinin synthase gene |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006-238691 | 2006-09-04 | ||
JP2006238691 | 2006-09-04 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/281,238 A-371-Of-International US8124834B2 (en) | 2006-09-04 | 2007-09-04 | Use of active cytokinin synthase gene |
US13/349,889 Continuation US8962920B2 (en) | 2006-09-04 | 2012-01-13 | Use of active cytokinin synthase gene |
US13/349,889 Division US8962920B2 (en) | 2006-09-04 | 2012-01-13 | Use of active cytokinin synthase gene |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008029942A1 true WO2008029942A1 (fr) | 2008-03-13 |
Family
ID=39157359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/067558 WO2008029942A1 (fr) | 2006-09-04 | 2007-09-04 | Utilisation du gène de l'enzyme de biosynthèse de la cytokinine activée |
Country Status (5)
Country | Link |
---|---|
US (2) | US8124834B2 (ja) |
EP (1) | EP2067859A4 (ja) |
JP (1) | JPWO2008029942A1 (ja) |
CN (1) | CN101511999A (ja) |
WO (1) | WO2008029942A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012057361A1 (ja) * | 2010-10-27 | 2012-05-03 | 独立行政法人理化学研究所 | 活性型サイトカイニン発現量制御による植物バイオマスの増大方法 |
WO2021074928A1 (en) * | 2019-10-18 | 2021-04-22 | Rajiv Gandhi Centre For Biotechnology | Method for increasing biomass of photosynthetic organism by extending its life in culture |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101511999A (zh) * | 2006-09-04 | 2009-08-19 | 独立行政法人理化学研究所 | 活性细胞***素合成酶基因的应用 |
KR20170007299A (ko) * | 2014-05-22 | 2017-01-18 | 다우 아그로사이언시즈 엘엘씨 | 시토키닌 신타제 효소, 구축물, 및 관련 방법 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072818A1 (fr) | 2001-03-12 | 2002-09-19 | Suntory Limited | Genes codant pour des proteines participant a la synthese de cytokinine |
JP2006238691A (ja) | 2005-02-22 | 2006-09-07 | Areva T & D Uk Ltd | 変流器の動作を管理するための方法および装置 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1586645A3 (en) | 1999-02-25 | 2006-02-22 | Ceres Incorporated | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
WO2003000898A1 (en) * | 2001-06-22 | 2003-01-03 | Syngenta Participations Ag | Plant genes involved in defense against pathogens |
AU2001289843A1 (en) | 2001-08-28 | 2002-02-13 | Bayer Cropscience Ag | Polypeptides for identifying herbicidally active compounds |
JP2005185101A (ja) * | 2002-05-30 | 2005-07-14 | National Institute Of Agrobiological Sciences | 植物の全長cDNAおよびその利用 |
US20040216190A1 (en) * | 2003-04-28 | 2004-10-28 | Kovalic David K. | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
CN101511999A (zh) * | 2006-09-04 | 2009-08-19 | 独立行政法人理化学研究所 | 活性细胞***素合成酶基因的应用 |
-
2007
- 2007-09-04 CN CNA2007800321585A patent/CN101511999A/zh active Pending
- 2007-09-04 JP JP2008533219A patent/JPWO2008029942A1/ja active Pending
- 2007-09-04 WO PCT/JP2007/067558 patent/WO2008029942A1/ja active Application Filing
- 2007-09-04 US US12/281,238 patent/US8124834B2/en not_active Expired - Fee Related
- 2007-09-04 EP EP07806990A patent/EP2067859A4/en not_active Withdrawn
-
2012
- 2012-01-13 US US13/349,889 patent/US8962920B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072818A1 (fr) | 2001-03-12 | 2002-09-19 | Suntory Limited | Genes codant pour des proteines participant a la synthese de cytokinine |
JP2006238691A (ja) | 2005-02-22 | 2006-09-07 | Areva T & D Uk Ltd | 変流器の動作を管理するための方法および装置 |
Non-Patent Citations (14)
Title |
---|
"New edition, Experimental protocols of model plants", 2001 |
ASHIKARI, M. ET AL.: "Cytokinin oxidase regulates rice grain production", SCIENCE, vol. 309, 2005, pages 741 - 745 |
DATABASE GENBANK [online] KIKUCHI S. ET AL.: "Collection, mapping, and annotation of over 28,000 cDNA clones from japonica rice", XP002274713, Database accession no. (AK071695) * |
DATABASE GENPEPT [online] SASAKI T. ET AL.: "The genome sequence and structure of rice chromosome 1", XP002256171, Database accession no. (BAD52880) * |
KURAKAWA T. ET AL.: "Direct control of shoot meristem activity by a cytokinin-activating enzyme", NATURE, vol. 445, no. 7128, February 2007 (2007-02-01), pages 652 - 655, XP003021636 * |
KURAKAWA T. ET AL.: "The analysis of LOG, a new regulator of shoot apical meristem activity in rice", PLANT AND CELL PHYSIOLOGY, vol. 47, no. SUPPL. S, May 2006 (2006-05-01), pages S76 + ABSTR. NO. 207, XP003021634 * |
NATURE, vol. 420, no. 6913, 2002, pages 312 - 316 * |
SAKAKIBARA H. ET AL.: "Cytokinin no Seigosei to Shinki no Kasseika Keiro", PROTEIN, NUCLEIC ACID AND ENZYME, vol. 52, no. 11, 1 September 2007 (2007-09-01), pages 1322 - 1329, XP003021635 * |
SAKAKIBARA, H.: "Cytokinins: Activity, biosynthesis and translocation", ANNU. REV. PLANT BIOL., vol. 57, 2006, pages 431 - 449 |
SCIENCE, vol. 301, no. 5631, 2003, pages 376 - 379 * |
See also references of EP2067859A4 |
UEDA N. ET AL.: "Ine Keicho Bunretsu Soshiki Iji ni Kakawaru LOG Idenshi wa Cytokinin Kasseika Koso o Code Shiteiru", THE JAPANESE SOCIETY OF PLANT PHYSIOLOGISTS NENKAI YOSHISHU, vol. 48TH, March 2007 (2007-03-01), pages 194 + ABSTR. NO. 3AD01(405), XP003021642 * |
WERNER T ET AL.: "Regulation of plant growth by cytokinin", PROC NATL ACAD SCI USA, vol. 98, 2001, pages 10487 - 10492, XP002240696, DOI: doi:10.1073/pnas.171304098 |
ZUBKO E ET AL.: "Activation tagging identifies a gene from Petunia hybrida responsible for the production of active cytokinins in plants", PLANT J., vol. 29, 2002, pages 797 - 808, XP002204543, DOI: doi:10.1046/j.1365-313X.2002.01256.x |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012057361A1 (ja) * | 2010-10-27 | 2012-05-03 | 独立行政法人理化学研究所 | 活性型サイトカイニン発現量制御による植物バイオマスの増大方法 |
US20130212743A1 (en) * | 2010-10-27 | 2013-08-15 | Riken | Method for increasing plant biomass by controlling active cytokinin expression level |
WO2021074928A1 (en) * | 2019-10-18 | 2021-04-22 | Rajiv Gandhi Centre For Biotechnology | Method for increasing biomass of photosynthetic organism by extending its life in culture |
Also Published As
Publication number | Publication date |
---|---|
US8962920B2 (en) | 2015-02-24 |
US20090317863A1 (en) | 2009-12-24 |
JPWO2008029942A1 (ja) | 2010-01-21 |
EP2067859A1 (en) | 2009-06-10 |
CN101511999A (zh) | 2009-08-19 |
EP2067859A4 (en) | 2009-12-02 |
US8124834B2 (en) | 2012-02-28 |
US20130198894A1 (en) | 2013-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Strizhov et al. | Differential expression of two P5CS genes controlling proline accumulation during salt‐stress requires ABA and is regulated by ABA1, ABI1 and AXR2 in Arabidopsis | |
CA2367408A1 (en) | Genetic trait breeding method | |
WO2002099079A2 (en) | Cytokinin response regulators and uses thereof | |
AU759068B2 (en) | Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase | |
US7226745B2 (en) | Plant vitamin E biosynthetic enzymes | |
WO2011049243A1 (ja) | バイオマスが増大し、かつ環境ストレス耐性が向上した形質転換植物およびその作出方法 | |
US8962920B2 (en) | Use of active cytokinin synthase gene | |
US20030126630A1 (en) | Plant sterol reductases and uses thereof | |
WO1997048793A9 (en) | Plant sterol reductases and uses thereof | |
US8013141B2 (en) | Promoter with high expression strength and over-expression in various tissues of plant, as well as application thereof | |
WO2001046434A1 (fr) | GENES TIRES DU RIZ CODANT LA GIBBERELLINE 3β-HYDROXYLASE, ET LEUR UTILISATION | |
US6548743B1 (en) | Transgenic plants expressing a dual-specificity MAPK phosphatase and uses thereof | |
US20030167513A1 (en) | Selection and use of isopropylmalate synthase (IPMS) mutants desensitized in L-leucine negative feedback control | |
AU782201B2 (en) | Gene coding for protein involved in cytokinin signal transduction | |
WO2001012798A2 (en) | Male sterile plants | |
US20030018995A1 (en) | Plants with a modified flower and seed development | |
US6831168B1 (en) | Aldehyde oxidase gene derived from plant and utilization thereof | |
Osteryoung et al. | Studies of a chloroplast-localized small heat shock protein in Arabidopsis | |
WO2000012713A1 (en) | Plant promoter sequence and uses therefor | |
KR101677073B1 (ko) | 뿌리 생장을 증진시키는 벼 유래 유전자 및 이의 용도 | |
WO2003007886A2 (en) | Plant ion channels and methods | |
JPH1118776A (ja) | プロトポルフィリノーゲンオキシダーゼ遺伝子およびその利用 | |
WO2000024867A2 (en) | Plant histidine biosynthetic enzymes | |
WO2006100573A1 (en) | Method for producing plants with increased biomass | |
AU2002330901A1 (en) | Plant ion channels and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780032158.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07806990 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2008533219 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12281238 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007806990 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |